![]() |
The skeptical eye of John Q Public |
There has been some skepticism recently about this blog, specifically about my ability to continue the Chronicles. It should be clear to anyone by now that the Nanox fairy tale is essentially finished, and the final, Chapter 11, is coming inevitably. With Nanox obtaining FDA clearance and CE Mark for its miracle CT-replacement device (using fraudulent submissions), securing a second assembler in India, bringing the management to the USA, and second-sourcing "chips" from Europe, there can't be any more reasonable excuses for the lack of ARC revenues. I mean, why would Nanox have to "deploy" free ARCs without any minimum subscription or maintenance agreements, if the fake ARCs were even marginally useful? So, it is obvious the ARCs, in addition to being fake, are not useful - Nanox says in its USA user manual that the ARC can be used only after the patient is scanned with another, regular x-ray device first (this warning was omitted for the rest of the world, for some reason).
All potential investors need to do is look at the utilization for the CPT code 76100 (publicly available from CMS) and check for clearances and recalls for the non-breast digital tomosynthesis devices that have been sold for decades...
So, don't hold your breath for the 15,000 ARCs deployed all over world by May 1, 2026 (as the "new" CEO "expected" in a signed 10K). As far as the rest of the "business" is concerned, I may have something interesting to say about the telerad and the AI things in the future (but that second thing is as good as dead because Nvidia finally got rid of the Nanox shares it had been holding).
No comments:
Post a Comment